Cytarabine

Curated

← predicts response to

IKZF1 Deletiondeletion_cna

sensitivity

Curated

← predicts response to

RUNX1 Mutationother

resistance

Curated

← predicts response to

PRPS1 L191FSNV

sensitivity

Curated

← predicts response to

PRPS1 N144SSNV

sensitivity

Curated

← predicts response to

FLT3 D835VSNV

sensitivity

Curated

← predicts response to

ZEB1 Expressionexpression

resistance

Mantle Cell Lymphoma

Curated

← predicts response to

NPM1 W288FSindel

sensitivity

Curated

Cytarabine targets …TARGETS11 of 11
→ targets	POLE2	—	INHIBITOR	—	1	Curated	chembl	graph →
→ targets	POLE3	—	INHIBITOR	—	1	Curated	chembl	graph →
→ targets	PRIM1	—	INHIBITOR	—	1	Curated	chembl	graph →
→ targets	PRIM2	—	INHIBITOR	—	1	Curated	chembl	graph →
→ targets	POLA2	—	INHIBITOR	—	1	Curated	chembl	graph →
→ targets	POLE	—	INHIBITOR	—	1	Curated	chembl	graph →
→ targets	POLD1	—	INHIBITOR	—	1	Curated	chembl	graph →
→ targets	POLD2	—	INHIBITOR	—	1	Curated	chembl	graph →
→ targets	POLD3	—	INHIBITOR	—	1	Curated	chembl	graph →
→ targets	POLD4	—	INHIBITOR	—	1	Curated	chembl	graph →
→ targets	POLA1	—	INHIBITOR	—	1	Curated	chembl	graph →

Cytarabine targets …TARGETS11 of 11

→ targets

POLE2

—

INHIBITOR

—

Curated

→ targets

POLE3

—

INHIBITOR

—

Curated

→ targets

PRIM1

—

INHIBITOR

—

Curated

→ targets

PRIM2

—

INHIBITOR

—

Curated

→ targets

POLA2

—

INHIBITOR

—

Curated

→ targets

POLE

—

INHIBITOR

—

Curated

→ targets

POLD1

—

INHIBITOR

—

Curated

→ targets

POLD2

—

INHIBITOR

—

Curated

→ targets

POLD3

—

INHIBITOR

—

Curated

→ targets

POLD4

—

INHIBITOR

—

Curated

→ targets

POLA1

—

INHIBITOR

—

Curated

Cytarabine investigated for …INVESTIGATED_FOR57 of 57show fewer
→ investigated for	Acute Myeloid Leukemiahematologic_malignancy 2 source records aggregated	supports	B	Acute Myeloid Leukemia	2	Curated	civic	graph →
→ investigated for	B Lymphoblastic Leukemia/Lymphomahematologic_malignancy	supports	B	B Lymphoblastic Leukemia/Lymphoma	1	Curated	civic	graph →
→ investigated for	Meningeal Neoplasmsubtype	unknown	4	Meningeal Neoplasm	1	Curated	chembl	graph →
→ investigated for	Meningeal Carcinomatosissubtype	unknown	4	Meningeal Carcinomatosis	1	Curated	chembl	graph →
→ investigated for	Lymphoid Leukemiahematologic_malignancy	unknown	4	Lymphoid Leukemia	1	Curated	chembl	graph →
→ investigated for	Neoplasmcancer_family	unknown	4	Neoplasm	1	Curated	chembl	graph →
→ investigated for	Acute Myeloid Leukemiahematologic_malignancy	unknown	4	Acute Myeloid Leukemia	1	Curated	chembl	graph →
→ investigated for	Acute Lymphoblastic Leukemiahematologic_malignancy	unknown	4	Acute Lymphoblastic Leukemia	1	Curated	chembl	graph →
→ investigated for	Myeloid Leukemiahematologic_malignancy	unknown	3	Myeloid Leukemia	1	Curated	chembl	graph →
→ investigated for	T Acute Lymphoblastic Leukemiahematologic_malignancy	unknown	3	T Acute Lymphoblastic Leukemia	1	Curated	chembl	graph →
→ investigated for	Breast Neoplasmcancer_family	unknown	3	Breast Neoplasm	1	Curated	chembl	graph →
→ investigated for	Myelodysplastic Syndromehematologic_malignancy	unknown	3	Myelodysplastic Syndrome	1	Curated	chembl	graph →
→ investigated for	Chronic Myelomonocytic Leukemiahematologic_malignancy	unknown	3	Chronic Myelomonocytic Leukemia	1	Curated	chembl	graph →
→ investigated for	Acute Erythroid Leukemiahematologic_malignancy	unknown	3	Acute Erythroid Leukemia	1	Curated	chembl	graph →
→ investigated for	Myeloid Sarcomacancer_family	unknown	3	Myeloid Sarcoma	1	Curated	chembl	graph →
→ investigated for	Non-Hodgkin Lymphomahematologic_malignancy	unknown	3	Non-Hodgkin Lymphoma	1	Curated	chembl	graph →
→ investigated for	Myeloproliferative Neoplasmhematologic_malignancy	unknown	3	Myeloproliferative Neoplasm	1	Curated	chembl	graph →
→ investigated for	Acute Megakaryoblastic Leukemiahematologic_malignancy	unknown	3	Acute Megakaryoblastic Leukemia	1	Curated	chembl	graph →
→ investigated for	Acute Basophilic Leukemiahematologic_malignancy	unknown	3	Acute Basophilic Leukemia	1	Curated	chembl	graph →
→ investigated for	Melanomacancer_family	unknown	3	Melanoma	1	Curated	chembl	graph →
→ investigated for	Multiple Myelomahematologic_malignancy	unknown	3	Multiple Myeloma	1	Curated	chembl	graph →
→ investigated for	Chronic Myeloid Leukemia, BCR-ABL1 Positivemolecular_subtype	unknown	3	Chronic Myeloid Leukemia, BCR-ABL1 Positive	1	Curated	chembl	graph →
→ investigated for	Acute Myelomonocytic Leukemiahematologic_malignancy	unknown	3	Acute Myelomonocytic Leukemia	1	Curated	chembl	graph →
→ investigated for	Hodgkin Lymphomahematologic_malignancy	unknown	3	Hodgkin Lymphoma	1	Curated	chembl	graph →
→ investigated for	Acute Monoblastic Leukemiahematologic_malignancy	unknown	3	Acute Monoblastic Leukemia	1	Curated	chembl	graph →
→ investigated for	Follicular Lymphomahematologic_malignancy	unknown	3	Follicular Lymphoma	1	Curated	chembl	graph →
→ investigated for	Mantle Cell Lymphomahematologic_malignancy	unknown	3	Mantle Cell Lymphoma	1	Curated	chembl	graph →
→ investigated for	Acute Biphenotypic Leukemiahematologic_malignancy	unknown	3	Acute Biphenotypic Leukemia	1	Curated	chembl	graph →
→ investigated for	Acute Promyelocytic Leukemiahematologic_malignancy	unknown	3	Acute Promyelocytic Leukemia	1	Curated	chembl	graph →
→ investigated for	Leukemiacancer_family	unknown	3	Leukemia	1	Curated	chembl	graph →
→ investigated for	Lymphomacancer_family	unknown	3	Lymphoma	1	Curated	chembl	graph →
→ investigated for	B Lymphoblastic Leukemia/Lymphomahematologic_malignancy 2 source records aggregated	supports	D	B Lymphoblastic Leukemia/Lymphoma	2	Curated	civic	graph →
→ investigated for	Acute Myeloid Leukemiahematologic_malignancy	supports	D	Acute Myeloid Leukemia	1	Curated	civic	graph →
→ investigated for	Mantle Cell Lymphomahematologic_malignancy	supports	D	Mantle Cell Lymphoma	1	Curated	civic	graph →
→ investigated for	Blastic Plasmacytoid Dendritic Cell Neoplasmhematologic_malignancy	unknown	2	Blastic Plasmacytoid Dendritic Cell Neoplasm	1	Curated	chembl	graph →
→ investigated for	Plasma Cell Neoplasmhematologic_malignancy	unknown	2	Plasma Cell Neoplasm	1	Curated	chembl	graph →
→ investigated for	Hematopoietic and Lymphoid Cell Neoplasmcancer_family	unknown	2	Hematopoietic and Lymphoid Cell Neoplasm	1	Curated	chembl	graph →
→ investigated for	Adult T-Cell Leukemia/Lymphomahematologic_malignancy	unknown	2	Adult T-Cell Leukemia/Lymphoma	1	Curated	chembl	graph →
→ investigated for	Ovarian Neoplasmsubtype	unknown	2	Ovarian Neoplasm	1	Curated	chembl	graph →
→ investigated for	Central Nervous System Neoplasmcancer_family	unknown	2	Central Nervous System Neoplasm	1	Curated	chembl	graph →
→ investigated for	Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positivemolecular_subtype	unknown	2	Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive	1	Curated	chembl	graph →
→ investigated for	AIDS-Related Lymphomahematologic_malignancy	unknown	2	AIDS-Related Lymphoma	1	Curated	chembl	graph →
→ investigated for	Juvenile Myelomonocytic Leukemiahematologic_malignancy	unknown	2	Juvenile Myelomonocytic Leukemia	1	Curated	chembl	graph →
→ investigated for	Anaplastic Large Cell Lymphomahematologic_malignancy	unknown	2	Anaplastic Large Cell Lymphoma	1	Curated	chembl	graph →
→ investigated for	Medulloblastomasubtype	unknown	2	Medulloblastoma	1	Curated	chembl	graph →
→ investigated for	Burkitt Lymphomahematologic_malignancy	unknown	2	Burkitt Lymphoma	1	Curated	chembl	graph →
→ investigated for	Peripheral T-Cell Lymphoma, Not Otherwise Specifiedhematologic_malignancy	unknown	2	Peripheral T-Cell Lymphoma, Not Otherwise Specified	1	Curated	chembl	graph →
→ investigated for	Chronic Lymphocytic Leukemiahematologic_malignancy	unknown	2	Chronic Lymphocytic Leukemia	1	Curated	chembl	graph →
→ investigated for	Sarcomacancer_family	unknown	2	Sarcoma	1	Curated	chembl	graph →
→ investigated for	Acute Myeloid Leukemiahematologic_malignancy	supports	E	Acute Myeloid Leukemia	1	Curated	civic	graph →
→ investigated for	Paragangliomasubtype	unknown	1	Paraganglioma	1	Curated	chembl	graph →
→ investigated for	Brain Neoplasmsubtype	unknown	1	Brain Neoplasm	1	Curated	chembl	graph →
→ investigated for	Primary Myelofibrosishematologic_malignancy	unknown	1	Primary Myelofibrosis	1	Curated	chembl	graph →
→ investigated for	Polycythemia Verahematologic_malignancy	unknown	1	Polycythemia Vera	1	Curated	chembl	graph →
→ investigated for	Glioblastomasubtype	unknown	1	Glioblastoma	1	Curated	chembl	graph →
→ investigated for	Essential Thrombocythemiahematologic_malignancy	unknown	1	Essential Thrombocythemia	1	Curated	chembl	graph →
→ investigated for	Plasma Cell Leukemiahematologic_malignancy	unknown	1	Plasma Cell Leukemia	1	Curated	chembl	graph →

Cytarabine investigated for …INVESTIGATED_FOR57 of 57show fewer

→ investigated for

Acute Myeloid Leukemiahematologic_malignancy

2 source records aggregated

supports

Curated

→ investigated for

B Lymphoblastic Leukemia/Lymphomahematologic_malignancy

supports

Curated

→ investigated for

Meningeal Neoplasmsubtype

unknown

Meningeal Neoplasm

Curated

→ investigated for

Meningeal Carcinomatosissubtype

unknown

Meningeal Carcinomatosis

Curated

→ investigated for

Lymphoid Leukemiahematologic_malignancy

unknown

Lymphoid Leukemia

Curated

→ investigated for

Neoplasmcancer_family

unknown

Neoplasm

Curated

→ investigated for

Acute Myeloid Leukemiahematologic_malignancy

unknown

Curated

Acute Lymphoblastic Leukemia

→ investigated for

Acute Lymphoblastic Leukemiahematologic_malignancy

unknown

Curated

→ investigated for

Myeloid Leukemiahematologic_malignancy

unknown

Myeloid Leukemia

Curated

T Acute Lymphoblastic Leukemia

→ investigated for

T Acute Lymphoblastic Leukemiahematologic_malignancy

unknown

Curated

→ investigated for

Breast Neoplasmcancer_family

unknown

Breast Neoplasm

Curated

→ investigated for

Myelodysplastic Syndromehematologic_malignancy

unknown

Myelodysplastic Syndrome

Curated

Chronic Myelomonocytic Leukemia

→ investigated for

Chronic Myelomonocytic Leukemiahematologic_malignancy

unknown

Curated

→ investigated for

Acute Erythroid Leukemiahematologic_malignancy

unknown

Acute Erythroid Leukemia

Curated

→ investigated for

Myeloid Sarcomacancer_family

unknown

Myeloid Sarcoma

Curated

→ investigated for

Non-Hodgkin Lymphomahematologic_malignancy

unknown

Non-Hodgkin Lymphoma

Curated

Myeloproliferative Neoplasm

→ investigated for

Myeloproliferative Neoplasmhematologic_malignancy

unknown

Curated

Acute Megakaryoblastic Leukemia

→ investigated for

Acute Megakaryoblastic Leukemiahematologic_malignancy

unknown

Curated

Acute Basophilic Leukemia

→ investigated for

Acute Basophilic Leukemiahematologic_malignancy

unknown

Curated

→ investigated for

Melanomacancer_family

unknown

Melanoma

Curated

→ investigated for

Multiple Myelomahematologic_malignancy

unknown

Multiple Myeloma

Curated

Chronic Myeloid Leukemia, BCR-ABL1 Positive

→ investigated for

Chronic Myeloid Leukemia, BCR-ABL1 Positivemolecular_subtype

unknown

Curated

Acute Myelomonocytic Leukemia

→ investigated for

Acute Myelomonocytic Leukemiahematologic_malignancy

unknown

Curated

→ investigated for

Hodgkin Lymphomahematologic_malignancy

unknown

Hodgkin Lymphoma

Curated

Acute Monoblastic Leukemia

→ investigated for

Acute Monoblastic Leukemiahematologic_malignancy

unknown

Curated

→ investigated for

Follicular Lymphomahematologic_malignancy

unknown

Follicular Lymphoma

Curated

→ investigated for

Mantle Cell Lymphomahematologic_malignancy

unknown

Mantle Cell Lymphoma

Curated

Acute Biphenotypic Leukemia

→ investigated for

Acute Biphenotypic Leukemiahematologic_malignancy

unknown

Curated

Acute Promyelocytic Leukemia

→ investigated for

Acute Promyelocytic Leukemiahematologic_malignancy

unknown

Curated

→ investigated for

Leukemiacancer_family

unknown

Leukemia

Curated

→ investigated for

Lymphomacancer_family

unknown

Lymphoma

Curated

→ investigated for

B Lymphoblastic Leukemia/Lymphomahematologic_malignancy

2 source records aggregated

supports

Curated

→ investigated for

Acute Myeloid Leukemiahematologic_malignancy

supports

Curated

→ investigated for

Mantle Cell Lymphomahematologic_malignancy

supports

Mantle Cell Lymphoma

Curated

Blastic Plasmacytoid Dendritic Cell Neoplasm

→ investigated for

Blastic Plasmacytoid Dendritic Cell Neoplasmhematologic_malignancy

unknown

Curated

→ investigated for

Plasma Cell Neoplasmhematologic_malignancy

unknown

Plasma Cell Neoplasm

Curated

Hematopoietic and Lymphoid Cell Neoplasm

→ investigated for

Hematopoietic and Lymphoid Cell Neoplasmcancer_family

unknown

Curated

Adult T-Cell Leukemia/Lymphoma

→ investigated for

Adult T-Cell Leukemia/Lymphomahematologic_malignancy

unknown

Curated

→ investigated for

Ovarian Neoplasmsubtype

unknown

Ovarian Neoplasm

Curated

Central Nervous System Neoplasm

→ investigated for

Central Nervous System Neoplasmcancer_family

unknown

Curated

Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive

→ investigated for

Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positivemolecular_subtype

unknown

Curated

→ investigated for

AIDS-Related Lymphomahematologic_malignancy

unknown

AIDS-Related Lymphoma

Curated

Juvenile Myelomonocytic Leukemia

→ investigated for

Juvenile Myelomonocytic Leukemiahematologic_malignancy

unknown

Curated

Anaplastic Large Cell Lymphoma

→ investigated for

Anaplastic Large Cell Lymphomahematologic_malignancy

unknown

Curated

→ investigated for

Medulloblastomasubtype

unknown

Medulloblastoma

Curated

→ investigated for

Burkitt Lymphomahematologic_malignancy

unknown

Burkitt Lymphoma

Curated

Peripheral T-Cell Lymphoma, Not Otherwise Specified

→ investigated for

Peripheral T-Cell Lymphoma, Not Otherwise Specifiedhematologic_malignancy

unknown

Curated

Chronic Lymphocytic Leukemia

→ investigated for

Chronic Lymphocytic Leukemiahematologic_malignancy

unknown

Curated

→ investigated for

Sarcomacancer_family

unknown

Sarcoma

Curated

→ investigated for

Acute Myeloid Leukemiahematologic_malignancy

supports

Curated

→ investigated for

Paragangliomasubtype

unknown

Paraganglioma

Curated

→ investigated for

Brain Neoplasmsubtype

unknown

Brain Neoplasm

Curated

→ investigated for

Primary Myelofibrosishematologic_malignancy

unknown

Primary Myelofibrosis

Curated

→ investigated for

Polycythemia Verahematologic_malignancy

unknown

Polycythemia Vera

Curated

→ investigated for

Glioblastomasubtype

unknown

Glioblastoma

Curated

Essential Thrombocythemia

→ investigated for

Essential Thrombocythemiahematologic_malignancy

unknown

Curated

→ investigated for

Plasma Cell Leukemiahematologic_malignancy

unknown

Plasma Cell Leukemia

Curated

Cytarabine investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 230show all (up to 200)
→ investigated in trials for	Acute Myeloid Leukemiahematologic_malignancy 298 trials (84 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Acute Myeloid Leukemia	298	Observed	clinicaltrials	graph →
→ investigated in trials for	Leukemiacancer_family 247 trials (12 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Leukemia	247	Observed	clinicaltrials	graph →
→ investigated in trials for	Lymphomacancer_family 129 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Lymphoma	129	Observed	clinicaltrials	graph →
→ investigated in trials for	Myelodysplastic Syndromehematologic_malignancy 120 trials (21 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Myelodysplastic Syndrome	120	Observed	clinicaltrials	graph →
→ investigated in trials for	Acute Lymphoblastic Leukemiahematologic_malignancy 97 trials (26 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Acute Lymphoblastic Leukemia	97	Observed	clinicaltrials	graph →
→ investigated in trials for	Adult Acute Myeloid Leukemia 80 trials (7 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Adult Acute Myeloid Leukemia	80	Observed	clinicaltrials	graph →
→ investigated in trials for	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 44 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	44	Observed	clinicaltrials	graph →
→ investigated in trials for	Acute Myeloid Leukemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 41 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Acute Myeloid Leukemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1	41	Observed	clinicaltrials	graph →
→ investigated in trials for	Secondary Acute Myeloid Leukemia 40 trials (7 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Secondary Acute Myeloid Leukemia	40	Observed	clinicaltrials	graph →
→ investigated in trials for	Adult Acute Monoblastic Leukemia 30 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Adult Acute Monoblastic Leukemia	30	Observed	clinicaltrials	graph →
→ investigated in trials for	Adult Acute Monocytic Leukemia 30 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Adult Acute Monocytic Leukemia	30	Observed	clinicaltrials	graph →
→ investigated in trials for	Adult Acute Myeloid Leukemia with Maturation 30 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Adult Acute Myeloid Leukemia with Maturation	30	Observed	clinicaltrials	graph →
→ investigated in trials for	Adult Acute Myeloid Leukemia without Maturation 30 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Adult Acute Myeloid Leukemia without Maturation	30	Observed	clinicaltrials	graph →
→ investigated in trials for	Adult Acute Myelomonocytic Leukemia 30 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Adult Acute Myelomonocytic Leukemia	30	Observed	clinicaltrials	graph →
→ investigated in trials for	Adult Erythroleukemia 28 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Adult Erythroleukemia	28	Observed	clinicaltrials	graph →

Cytarabine investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 230show all (up to 200)

→ investigated in trials for

Acute Myeloid Leukemiahematologic_malignancy

298 trials (84 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

298

Observed

→ investigated in trials for

Leukemiacancer_family

247 trials (12 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Leukemia

247

Observed

→ investigated in trials for

Lymphomacancer_family

129 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Lymphoma

129

Observed

→ investigated in trials for

Myelodysplastic Syndromehematologic_malignancy

120 trials (21 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Myelodysplastic Syndrome

120

Observed

Acute Lymphoblastic Leukemia

→ investigated in trials for

Acute Lymphoblastic Leukemiahematologic_malignancy

97 trials (26 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Observed

Adult Acute Myeloid Leukemia

→ investigated in trials for

80 trials (7 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Adult Acute Myeloid Leukemia

Observed

Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11

→ investigated in trials for

44 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11

Observed

Acute Myeloid Leukemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1

→ investigated in trials for

41 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Acute Myeloid Leukemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1

Observed

Secondary Acute Myeloid Leukemia

→ investigated in trials for

40 trials (7 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Secondary Acute Myeloid Leukemia

Observed

Adult Acute Monoblastic Leukemia

→ investigated in trials for

30 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Adult Acute Monoblastic Leukemia

Observed

Adult Acute Monocytic Leukemia

→ investigated in trials for

30 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Adult Acute Monocytic Leukemia

Observed

Adult Acute Myeloid Leukemia with Maturation

→ investigated in trials for

30 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Adult Acute Myeloid Leukemia with Maturation

Observed

Adult Acute Myeloid Leukemia without Maturation

→ investigated in trials for

30 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Adult Acute Myeloid Leukemia without Maturation

Observed

Adult Acute Myelomonocytic Leukemia

→ investigated in trials for

30 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Adult Acute Myelomonocytic Leukemia

Observed

→ investigated in trials for

Adult Erythroleukemia

28 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Adult Erythroleukemia

Observed

Cytarabine studied in …STUDIED_INderived10 of 1,008show all (up to 200)
→ studied in	NCT06377540Phase 2 · recruiting MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma · 1,008 trials list this drug (199 active)	—	—	Classic Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06917911Phase 2 · recruiting Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial) · 1,008 trials list this drug (199 active)	—	—	Core Binding Factor Acute Myeloid Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT03418038Phase 2 · recruiting Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia · 1,008 trials list this drug (199 active)	—	—	Lymphoma,Hodgkin Lymphoma,Chronic Myelomonocytic Leukemia+2	1	Observed	clinicaltrials	graph →
→ studied in	NCT05554393Phase 2 · recruiting Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial) · 1,008 trials list this drug (199 active)	—	—	Acute Myeloid Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT06124157Phase 2 · recruiting A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL) · 1,008 trials list this drug (199 active)	—	—	B Acute Lymphoblastic Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT05453903Phase 1 · active not recruiting A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies · 1,008 trials list this drug (199 active)	—	—	Acute Myeloid Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT05564390Phase 2 · recruiting MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) · 1,008 trials list this drug (199 active)	—	—	Myelodysplastic Syndrome,Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic/Myeloproliferative Neoplasm+2	1	Observed	clinicaltrials	graph →
→ studied in	NCT06317662Phase 2 · recruiting Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia · 1,008 trials list this drug (199 active)	—	—	Acute Leukemia of Ambiguous Lineage,B Acute Lymphoblastic Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT01511562Phase 2 · completed Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma · 1,008 trials list this drug (199 active)	—	—	Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02392429Phase 2 · active not recruiting FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia · 1,008 trials list this drug (199 active)	—	—	Acute Myeloid Leukemia	1	Observed	clinicaltrials	graph →

Cytarabine studied in …STUDIED_INderived10 of 1,008show all (up to 200)

→ studied in

NCT06377540Phase 2 · recruiting

MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma · 1,008 trials list this drug (199 active)

—

Classic Hodgkin Lymphoma

Observed

Core Binding Factor Acute Myeloid Leukemia

→ studied in

NCT06917911Phase 2 · recruiting

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial) · 1,008 trials list this drug (199 active)

—

Observed

Lymphoma,Hodgkin Lymphoma,Chronic Myelomonocytic Leukemia+2

→ studied in

NCT03418038Phase 2 · recruiting

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia · 1,008 trials list this drug (199 active)

—

Observed

→ studied in

NCT05554393Phase 2 · recruiting

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial) · 1,008 trials list this drug (199 active)

—

Observed

B Acute Lymphoblastic Leukemia

→ studied in

NCT06124157Phase 2 · recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL) · 1,008 trials list this drug (199 active)

—

Observed

→ studied in

NCT05453903Phase 1 · active not recruiting

A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies · 1,008 trials list this drug (199 active)

—

Observed

Myelodysplastic Syndrome,Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic/Myeloproliferative Neoplasm+2

→ studied in

NCT05564390Phase 2 · recruiting

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) · 1,008 trials list this drug (199 active)

—

Observed

Acute Leukemia of Ambiguous Lineage,B Acute Lymphoblastic Leukemia

→ studied in

NCT06317662Phase 2 · recruiting

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia · 1,008 trials list this drug (199 active)

—

Observed

→ studied in

NCT01511562Phase 2 · completed

Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma · 1,008 trials list this drug (199 active)

—

Lymphoma

Observed

→ studied in

NCT02392429Phase 2 · active not recruiting

FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia · 1,008 trials list this drug (199 active)

—

Observed